P37.4 Other congenital malaria

Name of the Condition

• Other congenital malaria (ICD-10-CM Code: P37.4)

Summary

This condition refers to congenital malaria, a rare infection in newborns caused by Plasmodium species, acquired from the mother during pregnancy or delivery. Manifestations vary based on parasite species, maternal immunity, and timing of exposure, with potential impacts on multiple organ systems.

Causes

Congenital malaria results from transplacental transmission of Plasmodium parasites from an infected mother to the fetus. The infection may also occur during delivery if the mother has active parasitemia. Maternal malaria, particularly with high parasite loads, increases transmission risk.

Risk Factors

• Maternal active malaria during pregnancy, especially with high parasitemia
• Lack of prenatal malaria screening or prophylaxis in endemic regions
• Maternal exposure to malaria-endemic areas without preventive measures
• Immunocompromised maternal status (e.g., HIV, malnutrition)

Symptoms

Symptoms may include fever, anemia, hepatosplenomegaly, jaundice, or neurologic abnormalities. Some infants may present with subtle signs or be asymptomatic at birth, with symptoms emerging later. Severe cases can involve respiratory distress or seizures.

Diagnosis

Diagnosis involves maternal history, newborn physical examination, and laboratory testing (e.g., blood smear, PCR, or rapid diagnostic tests) to detect Plasmodium parasites. Additional tests may assess anemia, liver function, or neurologic involvement. Maternal malaria history and timing of exposure are critical for evaluation.

Treatment Options

Treatment typically includes antimalarial medications (e.g., artemisinin-based combinations) tailored to the parasite species and infant age. Supportive care may address anemia, jaundice, or organ dysfunction. Close monitoring for treatment response and complications is essential.

Prognosis and Follow-Up

Prognosis depends on early diagnosis, parasite species, and prompt treatment. Most infants recover with appropriate therapy, but severe cases may have long-term effects (e.g., neurologic impairment). Follow-up includes monitoring for delayed symptoms and developmental assessments.

Complications

Potential complications include severe anemia, respiratory distress, seizures, or organ damage. Untreated or delayed treatment may increase mortality risk. Long-term sequelae, such as neurodevelopmental delays, can occur in severe cases.

Lifestyle & Prevention

Prevention focuses on maternal malaria prevention during pregnancy, including prophylaxis in endemic areas and insecticide-treated bed nets. Prenatal screening and prompt treatment of maternal malaria reduce transmission risk. Avoiding mosquito exposure and ensuring access to healthcare in endemic regions are key.

When to Seek Professional Help

Seek immediate medical attention if a newborn shows signs of infection (e.g., fever, poor feeding, jaundice) or if the mother had malaria during pregnancy. Early evaluation is critical for timely diagnosis and treatment.

Tips for Medical Coders

Document the specific Plasmodium species (if known) and timing of maternal infection. Include details on diagnostic methods (e.g., blood smear, PCR) and treatment. Ensure maternal malaria history and transmission route (transplacental vs. perinatal) are clearly recorded for accurate coding.